Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S., MRCPI
Endocrinologist
MRCP (UK), F.C.P.S (Medicine), F.C.P.S (Endocrine)
Endocrinologist
MRCP (UK), F.C.P.S (Medicine), F.C.P.S (Endocrine)
Internal Medicine Specialist
MBBS, MRCP II, FCPS (Medicine), Fellowship in Endocrinology
Internal Medicine Specialist
MBBS, MRCP II, FCPS (Medicine), Fellowship in Endocrinology
Pulmonologist
M.B.B.S., M.C.P.S, M.Phil (Anotomy), M.P.H., M.A.S.P
Pulmonologist
M.B.B.S., M.C.P.S, M.Phil (Anotomy), M.P.H., M.A.S.P
Gastroenterologist
M.B.B.S., F.C.P.S (Gastroenterology), FCPS Gastroenterology
Gastroenterologist
M.B.B.S., F.C.P.S (Gastroenterology), FCPS Gastroenterology
Endocrinologist
M.B.B.S., MSc., P.E.C
Cardiologist
M.B.B.S., F.C.P.S (Medicine), F.C.P.S (Cardiology)
Internal Medicine Specialist
M.B.B.S., M.C.P.S, F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures